K
Karolina A. Aberg
Researcher at Virginia Commonwealth University
Publications - 87
Citations - 3375
Karolina A. Aberg is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: DNA methylation & Epigenetics. The author has an hindex of 28, co-authored 75 publications receiving 2795 citations. Previous affiliations of Karolina A. Aberg include Uppsala University & VCU Medical Center.
Papers
More filters
Journal ArticleDOI
Association of Childhood Trauma Exposure With Adult Psychiatric Disorders and Functional Outcomes
William E. Copeland,Lilly Shanahan,Jennifer Hinesley,Robin F. Chan,Karolina A. Aberg,John A. Fairbank,Edwin J. C. G. van den Oord,E. Jane Costello +7 more
TL;DR: In this cohort study, cumulative childhood trauma was associated with higher rates of adult psychiatric disorders and poorer functional outcomes even after adjusting for a broad range of other childhood risk factors for these outcomes.
Journal ArticleDOI
Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults.
Karolina A. Aberg,Joseph L. McClay,Srilaxmi Nerella,Shaunna L. Clark,Gaurav Kumar,Wenan Chen,Amit N. Khachane,Linying Xie,Alexandra D. Hudson,Guimin Gao,Aki Harada,Christina M. Hultman,Patrick F. Sullivan,Patrick F. Sullivan,Patrik K. E. Magnusson,Edwin J. C. G. van den Oord +15 more
TL;DR: This methylome-wide association study of schizophrenia is one of the first MWASs of disease with a large sample size using a technology that provides good coverage of methylation sites across the genome and demonstratedone of the unique features ofmethylation studies that can capture signatures of environmental insults in peripheral tissues.
Journal ArticleDOI
Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia.
TL;DR: It is shown that human QKI mRNA levels can account for a high proportion of normal interindividual mRNA expression variation (and covariation) of six oligodendrocyte-related genes in 55 human brain autopsy samples from individuals without psychiatric diagnoses, and hypothesize that previously observed decreased activity of myelin- related genes in schizophrenia might be caused by disturbed QKI splicing.
Journal ArticleDOI
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
Daniel E. Adkins,Karolina A. Aberg,Joseph L. McClay,József Bukszár,Zhongming Zhao,Peilin Jia,T. S. Stroup,Diana O. Perkins,Joseph P. McEvoy,Jeffrey A. Lieberman,Patrick F. Sullivan,Patrick F. Sullivan,E J C G van den Oord +12 more
TL;DR: The potential of GWAS to discover genes and pathways that potentially mediate adverse effects of antipsychotic medication is shown, with the top finding indicated that a SNP in Meis homeobox 2 (MEIS2) mediated the effects of risperidone on hip circumference.
Journal ArticleDOI
A Comprehensive Family-Based Replication Study of Schizophrenia Genes
Karolina A. Aberg,Youfang Liu,József Bukszár,Joseph L. McClay,Amit N. Khachane,Ole A. Andreassen,Douglas Blackwood,Aiden Corvin,Srdjan Djurovic,Hugh Gurling,Roel A. Ophoff,Carlos N. Pato,Michele T. Pato,Brien P. Riley,Todd Webb,Kenneth S. Kendler,Michael Conlon O'Donovan,Nicholas John Craddock,George Kirov,Michael John Owen,Dan Rujescu,David St Clair,Thomas Werge,Christina M. Hultman,Lynn E. DeLisi,Patrick F. Sullivan,Patrick F. Sullivan,Edwin J. C. G. van den Oord +27 more
TL;DR: A meta-analysis of genome-wide association studies involving 1,085,772 single-nucleotide polymorphisms (SNPs) and 6 databases that showed significant informativeness for SCZ replicated novel SCZ disease genes and pathogenic pathways.